Literature DB >> 27927708

Clarithromycin-induced akathisia: a class effect of macrolides?

Ivie Imasuen Gbinigie1, Daniel Lasserson1.   

Abstract

Clarithromycin is an antibiotic of the macrolide family, which is commonly used in the treatment of respiratory tract infections. We report a woman aged 77 years with bronchiectasis who was prescribed oral clarithromycin for lower respiratory tract infection. She developed akathisia after 2 doses. On withdrawing the antibiotic, her symptoms resolved rapidly after 7 days. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27927708      PMCID： PMC5174771          DOI： 10.1136/bcr-2016-217421

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  4 in total

1.  Central nervous system disturbances following clarithromycin ingestion.

Authors:  J M Geiderman
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Akathisia with azithromycin.

Authors:  Amber Riesselman; Rif S El-Mallakh
Journal:  Ann Pharmacother       Date:  2015-05       Impact factor: 3.154

3.  Clarithromycin-induced mania in two patients with AIDS.

Authors:  S D Nightingale; F T Koster; G J Mertz; S D Loss
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

4.  Drug intolerance to high-dose clarithromycin among elderly patients.

Authors:  R J Wallace; B A Brown; D E Griffith
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803
  4 in total
  1 in total

1.  Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.

Authors:  Koen Demyttenaere; Johan Detraux; Giorgio Racagni; Kristof Vansteelandt
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.